Global Canine Influenza Vaccine Market Size to hit 2,562.1 million dollars by 2031: Coherent Market Insights [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
Companies covered: Zoetis Services LLC, Merck & Co., Inc., Covetrus, CSL Limited, Boehringer Ingelheim Animal Health USA Inc., and Elanco Burlingame, June 19, 2024 (GLOBE NEWSWIRE) -- The global canine influenza vaccine market size was estimated at USD million in 2024 and is expected to reach around USD million by 2031, registering a CAGR of 5.1% between 2024 and 2031, as per a recent report by Coherent Market Insights. Companionship and emotional benefits provided by pets is one of the major reasons for the rise in pet ownership worldwide. The growing humanization of pets has encouraged pet owners to spend more on the health and well-being of their pets. As more households are adopting dogs as pets in their households, the demand for canine influenza vaccines has increased substantially in the past few years. Request Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/6932 Market Dynamics The growth of the global canine influenza vaccine market is pri
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Summit Therapeutics downgraded at Citi on valuation [Seeking Alpha]Seeking Alpha
- MRK's Keytruda Combo Fails in Phase III Colorectal Cancer Study [Yahoo! Finance]Yahoo! Finance
- Merck to Present New Long-Term Data for Tulisokibart (MK-7240), an Investigational Anti-TL1A Monoclonal Antibody, in Inflammatory Bowel Disease at UEG Week 2024Business Wire
- Merck & Co. Inc. (MRK): A Good Undervalued Blue Chip Stock to Buy According to Analysts [Yahoo! Finance]Yahoo! Finance
- Merck's colorectal cancer therapy fails late-stage trial [CNBC]CNBC
MRK
Earnings
- 7/30/24 - Beat
MRK
Sec Filings
- 8/6/24 - Form 4
- 8/5/24 - Form 10-Q
- 7/30/24 - Form 8-K
- MRK's page on the SEC website